0
Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials
Kristian Wahlbeck, M.D., Ph.D.; Maxim Cheine, M.D.; Adib Essali, M.D., Ph.D., M.R.C.Psych.; Clive Adams, M.B., B.Ch., B.A.O., M.R.C.Psych., M.Sc.(Epid.)
Recurrence After Recovery From Major Depressive Disorder During 15 Years of Observational Follow-Up
Timothy I. Mueller, M.D.; Andrew C. Leon, Ph.D.; Martin B. Keller, M.D.; David A. Solomon, M.D.; Jean Endicott, Ph.D.; William Coryell, M.D.; Meredith Warshaw, M.S.S., M.A.; Jack D. Maser, Ph.D.
Medications Versus Cognitive Behavior Therapy for Severely Depressed Outpatients: Mega-Analysis of Four Randomized Comparisons
Robert J. DeRubeis, Ph.D.; Lois A. Gelfand, M.A.; Tony Z. Tang, M.A.; Anne D. Simons, Ph.D.
Therapeutic Drug Monitoring of Mood Stabilizers in Medicaid Patients With Bipolar Disorder
Steven C. Marcus, Ph.D.; Mark Olfson, M.D., M.P.H.; Harold A. Pincus, M.D.; Deborah A. Zarin, M.D.; David J. Kupfer, M.D.
Spectrum of Activity of Lamotrigine in Treatment-Refractory Bipolar Disorder
Joseph R. Calabrese, M.D.; Charles L. Bowden, M.D.; Susan L. McElroy, M.D.; John Cookson, M.D.; John Andersen, M.D.; Paul E. Keck, Jr., M.D.; Linda Rhodes, M.D.; Carolyn Bolden-Watson, Ph.D.; Jing Zhou, Ph.D.; John A. Ascher, M.D.
Treatment of Major Depression With Nortriptyline and Paroxetine in Patients With Ischemic Heart Disease
J. Craig Nelson, M.D.; John S. Kennedy, M.D.; Bruce G. Pollock, M.D., Ph.D.; Fouzia Laghrissi-Thode, M.D.; Meena Narayan, M.D.; Mitchell S. Nobler, M.D.; Deborah W. Robin, M.D.; Ivan Gergel, M.D.; James McCafferty, B.S.; Steven Roose, M.D.
Prefrontal Cortex 5-HT2 Receptors in Depression: An [18F]Setoperone PET Imaging Study
Jeffrey H. Meyer, M.D.; Shitij Kapur, M.D., Ph.D.; Sylvain Houle, M.D., Ph.D.; Jean DaSilva, Ph.D.; Beata Owczarek, B.Sc.; Gregory M. Brown, M.D., Ph.D.; Alan A. Wilson, Ph.D.; Sidney H. Kennedy, M.D.
Memory Self-Appraisal in Middle-Aged and Older Adults With the Apolipoprotein E-4 Allele
Gary W. Small, M.D.; Stephen T. Chen, M.D.; Scott Komo, M.S.; Linda Ercoli, Ph.D.; Susan Bookheimer, Ph.D.; Karen Miller, Ph.D.; Helen Lavretsky, M.D.; Sanjaya Saxena, M.D.; Andrea Kaplan, B.S.; Deborah Dorsey, R.N.; William K. Scott, Ph.D.; Ann M. Saunders, Ph.D.; Jonathan L. Haines, Ph.D.; Allen D. Roses, M.D.; Margaret A. Pericak-Vance, Ph.D.
Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer’s Disease
Clive Ballard, M.R.C.Psych., M.D.; Clive Holmes, M.R.C.Psych.; Ian McKeith, F.R.C.Psych., M.D.; David Neill, M.R.C.Psych., Ph.D.; John O’Brien, M.R.C.Psych., D.M.; Nigel Cairns, Ph.D.; Peter Lantos, M.D., F.R.C.Path.; Elaine Perry, Ph.D.; Paul Ince, M.D.; Robert Perry, M.D.
Normalization of Information Processing Deficits in Schizophrenia With Clozapine
Veena Kumari, Ph.D.; William Soni, M.B., B.S., M.Sc.; Tonmoy Sharma, M.Sc., M.R.C.Psych.
Electrophysiological Correlates of Language Processing in Schizotypal Personality Disorder
Margaret A. Niznikiewicz, Ph.D.; Martina Voglmaier, Ph.D.; Martha E. Shenton, Ph.D.; Larry J. Seidman, Ph.D.; Chandlee C. Dickey, M.D.; Richard Rhoads, M.A.; Enkeat Teh, M.A.; Robert W. McCarley, M.D.
Earlier Puberty as a Predictor of Later Onset of Schizophrenia in Women
Robin Z. Cohen, M.Sc.; Mary V. Seeman, M.D.; Andrew Gotowiec, Ph.D.; Lili Kopala, M.D.
Including Children and Adolescents With Schizophrenia in Medication-Free Research
Sanjiv Kumra, M.D., F.R.C.P.; Claudia Briguglio, R.N., M.N.; Marge Lenane, M.S.W.; Laura Goldhar; Jeffrey Bedwell, B.S.; Julia Venuchekov; Leslie K. Jacobsen, M.D.; Judith L. Rapoport, M.D.
Clinical Needs Assessment of Middle and High School Students Following the 1995 Oklahoma City Bombing
Betty Pfefferbaum, M.D., J.D.; Sara Jo Nixon, Ph.D.; Ronald S. Krug, Ph.D.; Rick D. Tivis, M.P.H.; Vern L. Moore, Ed.D.; Janice M. Brown, Ph.D.; Robert S. Pynoos, M.D., M.P.H.; David Foy, Ph.D.; Robin H. Gurwitch, Ph.D.
Anniversary Reactions in Gulf War Veterans: A Follow-Up Inquiry 6 Years After the War
Charles A. Morgan, III, M.D., M.A.; Susan Hill, C.I.S.W.; Patrick Fox, M.D.; Peter Kingham, B.A.; Steven M. Southwick, M.D.
Psychological Defense Styles in Women Who Report Childhood Sexual Abuse: A Controlled Community Study
Sarah E. Romans, M.D., F.R.A.N.Z.C.P.; Judy L. Martin, M.A.; Eleanor Morris, B.A.; G. Peter Herbison, M.Sc.
A Dilemma Born of Progress: Switching From Clozapine to a Newer Antipsychotic
Seth Rafal, M.D.; Ming T. Tsuang, M.D., Ph.D.; William T. Carpenter, Jr., M.D.
Subgenual Cingulate Cortex Volume in First-Episode Psychosis
Yoshio Hirayasu, M.D., Ph.D.; Martha E. Shenton, Ph.D.; Dean F. Salisbury, Ph.D.; Jun Soo Kwon, M.D., Ph.D.; Cynthia G. Wible, Ph.D.; Iris A. Fischer, B.A.; Deborah Yurgelun-Todd, Ph.D.; Carlos Zarate, M.D.; Ron Kikinis, M.D.; Ferenc A. Jolesz, M.D.; Robert W. McCarley, M.D.
Awareness of Illness and Subjective Experience of Cognitive Complaints in Patients With Bipolar I and Bipolar II Disorder
Stefano Pallanti, M.D., Ph.D.; Leonardo Quercioli, M.D.; Adolfo Pazzagli, M.D.; Alessandro Rossi, M.D.; Liliana Dell’Osso, M.D.; Stefano Pini, M.D., Ph.D.; Giovanni Battista Cassano, M.D.
Relationship of Awareness of Dyskinesia in Schizophrenia to Insight Into Mental Illness
Celso Arango, M.D.; Helene Adami, M.S.W.; Jay D. Sherr, Pharm.D.; Gunvant K. Thaker, M.D.; William T. Carpenter, Jr., M.D.
Association Between Prenatal Exposure to Poliovirus Infection and Adult Schizophrenia
Jaana Suvisaari, M.D.; Jari Haukka, Ph.D.; Antti Tanskanen, B.Sc.; Tapani Hovi, M.D., Ph.D.; Jouko Lönnqvist, M.D., Ph.D.
Antibodies to Heat Shock Proteins in Schizophrenic Patients: Implications for the Mechanism of the Disease
Markus J. Schwarz, M.D.; Michael Riedel, M.D.; Rudolf Gruber, M.D.; Manfred Ackenheil, M.D.; Norbert M�, M.D.
Quantitative Volumetric MRI Study of the Cerebellum and Vermis in Schizophrenia: Clinical and Cognitive Correlates
James J. Levitt, M.D.; Robert W. McCarley, M.D.; Paul G. Nestor, Ph.D.; Creola Petrescu, B.S.; Robert Donnino, B.A.; Yoshio Hirayasu, M.D., Ph.D.; Ron Kikinis, M.D.; Ferenc A. Jolesz, M.D.; Martha E. Shenton, Ph.D.
Olanzapine-Induced Mania
MARY JO FITZ-GERALD, M.D.; HAROLD B. PINKOFSKY, M.D., PH.D.; GUY BRANNON, M.D.; EVELYN DANDRIDGE, R.N.; ANDREW CALHOUN, M.D.
Quinapril and Depression
HANDAN GUNDUZ, M.D.; JOSEPH L. GEORGES, M.D.; STEWART FLEISHMAN, M.D.
Risperidone Monotherapy for Mania and Depression
HSIEN-YUAN LANE, M.D.; WEI-CHE CHIU, M.D.; WEN-HO CHANG, M.D.
Olanzapine-Induced Neuroleptic Malignant Syndrome With Mental Retardation
HOWARD C. MARGOLESE, M.D.; GUY CHOUINARD, M.D., M.SC.(PHARMACOL.)
Possible Nefazodone Withdrawal Syndrome
MICHAEL KOTLYAR, PHARM.D.; MICHAEL GOLDING, M.D.; EDWIN R. BREWER, M.C., PHARM.D.; STANLEY W. CARSON, PHARM.D.
Treating Visual Hallucinations With Donepezil
WILLIAM J. BURKE, M.D.; WILLIAM H. ROCCAFORTE, M.D.; STEVEN P. WENGEL, M.D.
Olanzapine Overdose
DAVID M. GARDNER, PHARM.D.; JACQUELINE MILLIKEN, M.B., F.R.C.P.C.; SERDAR M. DURSUN, M.D., PH.D.
Amiodarone-Induced Delirium
JOHN J. BARRY, M.D.; KRISTAL FRANKLIN, PHARM.D.
Clozapine for Substance-Abusing Schizophrenic Patients
JOHN W. TSUANG, M.D.; THAD E. ECKMAN, PH.D.; ANDREW SHANER, M.D.; STEPHEN R. MARDER, M.D.
Depression From Interferon Therapy in Patients With Hepatitis C
HITOSHI MIYAOKA, M.D.; TEMPEI OTSUBO, M.D.; KUNITOSHI KAMIJIMA, M.D.; MAKOTO ISHII, M.D.; MAKOTO ONUKI, M.D.; KEIJI MITAMURA, M.D.
Smoking in First-Episode Patients With Schizophrenia
JOSEPH P. MCEVOY, M.D.; SHIRLEY BROWN, R.N.
Clozapine to Olanzapine
R.C. MILLSON, M.D.; N.J. DELVA, M.D.
Psychopharmacologic Calvinism
ROBERT HIERHOLZER, M.D.
Valproate for Alcoholics With Bipolar Disorder
SUSAN C. SONNE, PHARM.D.; KATHLEEN T. BRADY, M.D., PH.D.
Ketanserin Treatment of Tourette’s Syndrome in Children
CHRISTINE BONNIER, M.D.; MARIE-CÉCILE NASSOGNE, M.D.; PHILIPPE EVRARD, M.D.
Dr. Luchins and Colleagues Reply
DANIEL J. LUCHINS, M.D.; PATRICIA HANRAHAN, PH.D.; DAVID KLASS, M.D.; RANDY MALAN, R.PH.; JOHN HARRIS, M.A.
Dr. Bagby and Colleagues Reply
R. MICHAEL BAGBY, PH.D., C.PSYCH.; NEIL A. RECTOR, PH.D., C.PSYCH.; ROBERT D. LEVITAN, M.D.; SIDNEY H. KENNEDY, M.D.
Neuroleptic Discontinuation and Tardive Dyskinesia Risk
JAY D. SHERR, PHARM.D.; DEBORAH MEDOFF, PH.D.; GUNVANT THAKER, M.D.
Dr. van Harten and Colleagues Reply
PETER N. VAN HARTEN, M.D., PH.D.; HANS W. HOEK, M.D., PH.D.; GLENN E. MATROOS, M.D.; MAARTEN KOETER, PH.D.; RENE S. KAHN, M.D., PH.D.
Risperidone and Clozapine for Treatment-Resistant Schizophrenia
EDUARDO DUNAYEVICH, M.D.; ANJAN CHATTERJEE, M.D.
Drs. Bondolfi and Baumann Reply
GUIDO BONDOLFI, M.D.; PIERRE BAUMANN, PH.D.
Fetal Alcohol Exposure and Adult Psychiatric Disorders
ABRAHAM RUDNICK, M.D., DIPL.PSYCH.; ASHER ORNOY, M.D.
Dr. Famy and Colleagues Reply
CHRIS FAMY, B.S.; ANN P. STREISSGUTH, PH.D.; ALAN S. UNIS, M.D.
Treatment of Panic Disorder
ISAAC MARKS, M.D., F.R.C.PSYCH.
Drs. Broocks and Bandelow Reply
ANDREAS BROOCKS, M.D.; BORWIN BANDELOW, M.D.
Lithium Discontinuation
MARIO MAJ, M.D., PH.D.
Dr. Coryell and Colleagues Reply
WILLIAM H. CORYELL, M.D.; ANDREW C. LEON, PH.D.; WILLIAM SCHEFTNER, M.D.